CL2017000644A1 - Compuestos esteroides c-20, composiciones y usos de estos para tratar lesiones cerebrales traumáticas (tbi), incluidas concusiones. - Google Patents

Compuestos esteroides c-20, composiciones y usos de estos para tratar lesiones cerebrales traumáticas (tbi), incluidas concusiones.

Info

Publication number
CL2017000644A1
CL2017000644A1 CL2017000644A CL2017000644A CL2017000644A1 CL 2017000644 A1 CL2017000644 A1 CL 2017000644A1 CL 2017000644 A CL2017000644 A CL 2017000644A CL 2017000644 A CL2017000644 A CL 2017000644A CL 2017000644 A1 CL2017000644 A1 CL 2017000644A1
Authority
CL
Chile
Prior art keywords
tbi
compositions
traumatic brain
steroid compounds
brain injuries
Prior art date
Application number
CL2017000644A
Other languages
English (en)
Inventor
Daniel E Levy
Original Assignee
Prevacus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevacus Inc filed Critical Prevacus Inc
Publication of CL2017000644A1 publication Critical patent/CL2017000644A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS ESTEROIDES C-20, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y USO DE LOS MISMOS PARA TRATAR, MINIMIZAR O PREVENIR TBI.</p>
CL2017000644A 2014-09-17 2017-03-16 Compuestos esteroides c-20, composiciones y usos de estos para tratar lesiones cerebrales traumáticas (tbi), incluidas concusiones. CL2017000644A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462051898P 2014-09-17 2014-09-17
US201462052457P 2014-09-18 2014-09-18

Publications (1)

Publication Number Publication Date
CL2017000644A1 true CL2017000644A1 (es) 2018-04-02

Family

ID=55533838

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000644A CL2017000644A1 (es) 2014-09-17 2017-03-16 Compuestos esteroides c-20, composiciones y usos de estos para tratar lesiones cerebrales traumáticas (tbi), incluidas concusiones.

Country Status (18)

Country Link
US (3) US20160168190A1 (es)
EP (1) EP3194417B1 (es)
JP (1) JP2017527603A (es)
KR (1) KR20170103745A (es)
CN (1) CN107108689A (es)
AU (1) AU2015317652A1 (es)
BR (1) BR112017005168A2 (es)
CA (2) CA2961630C (es)
CL (1) CL2017000644A1 (es)
EA (1) EA201790430A1 (es)
ES (1) ES2855993T3 (es)
IL (1) IL251239A0 (es)
PH (1) PH12017500500A1 (es)
SG (1) SG11201702118YA (es)
TW (1) TW201625660A (es)
UY (1) UY36305A (es)
WO (1) WO2016044559A1 (es)
ZA (1) ZA201701975B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240132250A (ko) 2021-10-19 2024-09-03 오라제닉스, 인코포레이티드 뇌진탕을 포함한 외상성 뇌 손상(tbi)의 치료를 위한 호흡 구동식 비강 디바이스 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248390A (en) * 1963-10-10 1966-04-26 Syntex Corp 19-nor-10alpha-pregnene and delta1(10)-19-nor-5alpha-pregnene compounds
FR2097045A1 (en) * 1970-07-30 1972-03-03 Roussel Uclaf 17-ethynylgon-4-en-3-ones - with progestomimetic activity useful as contraceptives and for gynaecological disorders
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US7473687B2 (en) * 2005-03-24 2009-01-06 Emory University Methods for the treatment of a traumatic central nervous system injury
EP2260052A4 (en) * 2008-02-26 2013-01-16 Univ Emory STEROIDANALOGA FOR NEUROPROTEKTION
EP3572417B1 (en) * 2011-10-14 2025-12-17 Sage Therapeutics, LLC 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
CN103073612B (zh) * 2013-02-04 2015-11-04 山东大学 醋酸乌利司他关键中间体的制备方法
UY36741A (es) * 2015-06-21 2016-12-30 Prevacus Inc Compuesto de esteroide c-20, sus composiciones y usos para tratar la lesión cerebral traumática (tbi), que incluye las conmociones cerebrales

Also Published As

Publication number Publication date
WO2016044559A1 (en) 2016-03-24
BR112017005168A2 (pt) 2018-01-23
EP3194417B1 (en) 2020-10-28
JP2017527603A (ja) 2017-09-21
CA2961630A1 (en) 2016-03-24
ES2855993T3 (es) 2021-09-27
PH12017500500A1 (en) 2017-08-30
KR20170103745A (ko) 2017-09-13
CA2961630C (en) 2025-12-09
ZA201701975B (en) 2019-06-26
US20250206774A1 (en) 2025-06-26
SG11201702118YA (en) 2017-04-27
TW201625660A (zh) 2016-07-16
UY36305A (es) 2016-04-29
EP3194417A1 (en) 2017-07-26
US20240409576A1 (en) 2024-12-12
CA3258074A1 (en) 2025-04-07
CN107108689A (zh) 2017-08-29
EA201790430A1 (ru) 2017-08-31
EP3194417A4 (en) 2018-12-19
US20160168190A1 (en) 2016-06-16
IL251239A0 (en) 2017-05-29
AU2015317652A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
CO2021007068A2 (es) Degradadores de irak y usos de los mismos
UY36741A (es) Compuesto de esteroide c-20, sus composiciones y usos para tratar la lesión cerebral traumática (tbi), que incluye las conmociones cerebrales
SV2018005794A (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos
MX2018016273A (es) Compuestos heterociclicos como inmunomoduladores.
GT201600233A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7
CL2017001046A1 (es) Inhibidoes del bromodominio
GT201700189A (es) Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
CL2017000576A1 (es) Inhibidores de mk2 y sus usos
MX2018003491A (es) Represores de htt y usos de estos.
MX2016014308A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7.
CO2019012767A2 (es) Compuesto de fenil-2-hidroxi-acetilamino-2-metil-fenilo
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
CL2017000372A1 (es) Composiciones novedosas, usos y métodos para hacerlas.
BR112017017970A2 (pt) composição de fragrância e combinação de fragrâncias
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
BR112017019154A2 (pt) uso de frações isoladas de goma mástica para o tratamento de neuropatia óptica
CU20180044A7 (es) Derivados novedosos de diamino piridina
CL2017000644A1 (es) Compuestos esteroides c-20, composiciones y usos de estos para tratar lesiones cerebrales traumáticas (tbi), incluidas concusiones.
ECSP17063489A (es) Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos
PY1735113A (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos
CR20190028A (es) Compuestos heterocíclicos como inmunomoduladores